Carl Zeiss Meditec AG (OTCMKTS:CZMWY) Short Interest Update

Carl Zeiss Meditec AG (OTCMKTS:CZMWY) was the recipient of a significant decline in short interest in the month of March. As of March 31st, there was short interest totaling 2,690 shares, a decline of 40.8% from the March 15th total of 4,541 shares. Based on an average daily volume of 6,170 shares, the days-to-cover ratio is presently 0.4 days.

Carl Zeiss Meditec Stock Performance

Carl Zeiss Meditec stock opened at $30.28 on Monday. Carl Zeiss Meditec has a 1 year low of $26.65 and a 1 year high of $75.01. The firm has a 50 day moving average price of $29.91 and a 200 day moving average price of $41.91.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on CZMWY. Sanford C. Bernstein downgraded shares of Carl Zeiss Meditec to a “market perform” rating in a report on Monday, January 26th. The Goldman Sachs Group downgraded shares of Carl Zeiss Meditec from a “buy” rating to a “neutral” rating in a report on Tuesday, January 20th. One research analyst has rated the stock with a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold”.

About Carl Zeiss Meditec

Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.

The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.